RxDoctor Payments Data

Trupti Gokani

Neurology · Glenview, ILNPI 1780638205

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $92,607 of the $126,218 with a category attached, or 73.4%. Teva Pharmaceuticals USA, Inc. accounts for 76.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $58,348 and has fallen 95.7% since, to $2,499 in 2025. Among neurology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$126,218in general payments, 2019–2025

Across 161 payments — averaging $783.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$97K
  • AbbVie$13K
  • Lundbeck LLC$9K
  • Amgen$6K
  • Biohaven Pharmaceuticals, Inc.$1K
  • Axsome Therapeutics, Inc.$184
  • plus $249 from 4 others

What the payments were for

  • Consulting fees$20,90617%
  • Speaking & faculty fees$92,60773%
  • Travel & lodging$8,3027%
  • Food & beverage$4,4033%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$126,218 in reported general payments places this provider in the 95th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois →

Other neurology in Glenview

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →